Awarded
1ª prorroga COMPLEJO PROTROMBINICO 500 UI PARENTERAL: Factor II, VII, IX, X, Proteina C y S.
- Contract value
- €554,625
- Bids received
- 3
- Published
- 18 Feb 2026
- Awarded
- 18 Feb 2026
- Contract start
- 18 Feb 2026
- Contract end
- 19 Feb 2027estimated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| SUMINISTRO, INSTALACIÓN Y PUESTA EN FUNCIONAMIENTO DE LA INFRAESTRUCTURA SUSPENDIDA Y DE LOS SISTEMAS DE INTEGRACIÓN PARA EL NUEVO BLOQUE QUIRÚRGICO DE CIRUGÍA MAYOR AMBULATORIA, EN EL HOSPITAL CLÍNICO SAN CARLOS DE MADRID | HOSPITAL CLINICO SAN CARLOS | PRIM, S.A. | €2,334,896 | 16 Sept 2026 |
| RYSTIGGO 140 MG/ML
SOLUCION INYECTABLE, 1 vial
de 3 ml | HOSPITAL CLINICO SAN CARLOS | UCB PHARMA S.A. | €296,836 | 3 Sept 2026 |
| RYSTIGGO 140 MG/ML
SOLUCION INYECTABLE, 1 vial
de 2 ml | HOSPITAL CLINICO SAN CARLOS | UCB PHARMA S.A. | €65,937 | 3 Sept 2026 |
| BRIVIACT 10 MG/ML SOLUCION
INYECTABLE Y
PARA PERFUSION 5 ML | HOSPITAL CLINICO SAN CARLOS | UCB PHARMA S.A. | €69,930RV | 3 Sept 2026 |
| BRIVIACT 10 MG/ML SOLUCION
INYECTABLE Y
PARA PERFUSION 5 ML | HOSPITAL CLINICO SAN CARLOS | UCB PHARMA S.A. | €69,930RV | 3 Sept 2026 |
| ABILIFY MAINTENA 720 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA | HOSPITAL CLINICO SAN CARLOS | OTSUKA PHARMACEUTICAL S.A. | €60,737 | 1 Sept 2026 |